Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2 Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 120 Mesothelioma 70 Solid Tumor 46 Solid Tumors 33 Retinoblastoma 27 Solitary Fibrous Tumor, Pleural 20 Sarcoma 17 Advanced Solid Tumor 16 Advanced Solid Tumors 15 Lung Neoplasms 13 Small Cell Lung Carcinoma 12 Carcinoma, Non-Small-Cell Lung 11 Osteosarcoma 9 Neuroblastoma 8 Ovarian Neoplasms 7 Unspecified Adult Solid Tumor, Protocol Specific 6 Solid Tumor, Adult 6 Colorectal Neoplasms 6 Cholangiocarcinoma 6 Central Nervous System Neoplasms 6 Carcinoma, Renal Cell 6 Uterine Cervical Neoplasms 5 Thyroid Neoplasms 5 Stomach Neoplasms 5 Neoplasms 5 Melanoma 5 Medulloblastoma 5 Chondrosarcoma 5 Carcinoma, Hepatocellular 5 Breast Neoplasms 5

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Low-grade Glioma × Other solid neoplasm × Clear all

NCT04775485 2025-04-10

FIREFLY-1

Day One Biopharmaceuticals, Inc.

Phase 2 Recruiting

141 enrolled 1 FDA

CNSOther solid neoplasm

Low-grade Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡